Treatment of Botulism in Wound Botulism with Injection Drug Use as a Risk Factor
Wound botulism occurs when a wound becomes colonized with toxin-producing bacteria, creating the conditions for systemic flaccid paralysis. Injection drug use — particularly use of black tar heroin — is a recognised risk factor for this presentation.
This protocol addresses wound botulism where injection drug use, especially black tar heroin, is the identified risk factor. The wound provides an anaerobic environment that supports clostridial colonization and local toxin production. Management must be tailored to each patient's individual clinical situation.
The central objective is to halt progression of flaccid paralysis. Neurologic signs should not continue to worsen beyond one day following antitoxin administration. Preventing further deterioration — including respiratory compromise — is the measure of timely intervention.
References
- Risk factors for wound botulism include injection drug use (especially of black tar heroin) and for foodborne botulism include consumption of home-canned food.
- Wound botulism is caused by clostridial colonization of an anaerobic wound, treatment of which is generally centered on debridement; treatment should address each patient's clinical situation.
- Treatment involves supportive care, intubation and mechanical ventilation when necessary, and administration of equine-derived botulinum antitoxin.
- When administered early in the course of illness (within 48 hours of symptom onset and ideally within 24 hours), botulinum antitoxin can stop the progression of paralysis and prevent respiratory compromise in certain patients.
- If neurologic signs progress for >1 day after administration of one vial of BAT, consider diagnoses other than botulism.